Loading...

A AGILENT TECHNOLOGIES INC Business Restructuring 8-K Filing

GLNT

AGILENT TECHNOLOGIES INC

(A)

2024 8-K

Show Summary

Show Summary

Director Resignation

Annual Meeting Results

Segment Changes

Financial Results

Operational Reorganization

Financial Results

Operational Reorganization

Senior Notes Offering

Segment Changes

Q3 Financial Results

Financial Results and Stock...

Amendment to CEO Compensation

Departure of Directors

Management Changes

Annual Meeting of Stockholders

Earnings Report

Management Changes

Reorganization of Business ...

Integration of Cell Analysi...

Earnings Reports

Resignation of Senior VP

Resignation of Senior VP

Earnings Reports

Credit Agreement

Financial Results Announcement

Amendment to Bylaws

Annual Meeting of Stockholders

Financial Results Announcement

Stock Repurchase Program

External Links:

Agilent Technologies announced the reorganization of its business segments, moving the Cell Analysis Division into the Diagnostics and Genomics Group (DGG) from the Life Sciences and Applied Markets Group (LSAG) to enhance growth opportunities.

AI Assistant

AGILENT TECHNOLOGIES INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.